Elizabeth Holmes, the founder and former CEO of Theranos, once sought a book deal to tell her side of the company's unraveling, which, the Wall Street Journal, writes raises the possibility she might testify at her upcoming trial next week.
Theranos was once valued at $9 billion, but, as series of article in the Journal beginning in 2015 reported, questions arose over whether the company was able to perform the blood tests it said it could. A Centers for Medicare & Medicaid Services inspection further uncovered serious problems at the firm's labs, which led to Holmes and Ramesh 'Sunny' Balwani, then the company's president, being barred from owning or operating a lab for two years.
Holmes and Balwani were also indicted on wire charges, and prosecutors allege that Holmes and Balwani committed fraud as they knew Theranos could not perform the tests as claimed. Both have pleaded not guilty.
As the Journal notes, Holmes' trial is to begin next week. It adds the revelations that she sought a book deal and has been adamant that she did nothing wrong suggests that she may testify at the trial. It adds that her attorneys are arguing that she thought the company would succeed.